Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL7777954 | 1.00 | CD81 (0.32) | CD81GRIK1 | |
| Trimethylammonium SCHEMBL998562 | 1.00 | CD81 (0.32) | CD81GRIK1 | |
| Trimethylammonium SCHEMBL8162325 | 0.98 | CD81 (0.33) | CD81GRIK1 | |
| Trimethylammonium SCHEMBL8162321 | 0.98 | CD81 (0.33) | CD81GRIK1 | |
| SCHEMBL27793 | 0.92 | CD81 (0.35) | CD81GRIK1 | |
| SCHEMBL150232 | 0.92 | CD81 (0.35) | CD81GRIK1 | |
| Acetone SCHEMBL29420371 | 0.90 | CD81 (0.34) | CD81GRIK1 | |
| Hydrochloric Acid SCHEMBL8601578 | 0.87 | CHRM2 (0.31) | — | |
| Phosphoric Acid SCHEMBL10601557 | 0.84 | CD81 (0.32) | CD81GRIK1 | |
| Methacrylic Acid SCHEMBL28014553 | 0.84 | CD81 (0.32) | CD81GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9823235-B2 | Droplet interfaces | Oxford Nanopre Technologies Ltd. (GB) | 2017-11-21 | — | — | US | claimed |
| US-20150285781-A1 | DROPLET INTERFACES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2015-10-08 | — | — | US | claimed |
| EP-2911771-A1 | DROPLET INTERFACES | Oxford Nanopore Technologies Limited (GB) | 2015-09-02 | — | — | EP | claimed |
| WO-2014064444-A1 | DROPLET INTERFACES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2014-05-01 | — | — | WO | claimed |
| EP-0820601-B1 | POLYSILOXANE-COMPRISING PERFLUOROALKYL ETHERS, AND THE PREPARATION AND USE THEREOF | NOVARTIS AG (CH) | 1999-12-22 | — | — | EP | claimed |
| US-5945498-A | CONTACT LENSES; CORNEAL IMPLANTS | NOVARTIS AG (CH) | 1999-08-31 | — | — | US | claimed |
| EP-0820601-A1 | POLYSILOXANE-COMPRISING PERFLUOROALKYL ETHERS, AND THE PREPARATION AND USE THEREOF | Novartis AG (CH) | 1998-01-28 | — | — | EP | claimed |
| WO-1996031791-A1 | POLYSILOXANE-COMPRISING PERFLUOROALKYL ETHERS, AND THE PREPARATION AND USE THEREOF | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | claimed |
| US-11745146-B2 | Method for biological or biomimetic channel-based membrane fabrications using layer-by-layer structure | THE PENN STATE RESEARCH FOUNDATION (US) | 2023-09-05 | — | — | US | disclosed |
| US-11541360-B2 | Process for making membranes | APPLIED BIOMIMETIC A/S (DK) | 2023-01-03 | — | — | US | disclosed |
| US-20220387941-A1 | PROCESS FOR MAKING MEMBRANES | APPLIED BIOMIMETIC A/S (DK) | 2022-12-08 | — | — | US | disclosed |
| US-20220118408-A1 | ORGANIC SOLVENT METHOD FOR PREPARING MEMBRANE PROTEIN BASED NANOSHEETS AND MEMBRANES BASED ON NANOSHEETS | THE PENN STATE RESEARCH FOUNDATION | 2022-04-21 | — | — | US | disclosed |
| US-11235286-B2 | Organic solvent method for preparing membrane protein based nanosheets and membranes based on nanosheets | THE PENN STATE RESEARCH FOUNDATION (US) | 2022-02-01 | — | — | US | disclosed |
| US-11154822-B2 | Method for biological or biomimetic channel-based membrane fabrications using layer-by-layer structure | THE PENN STATE RESEARCH FOUNDATION (US) | 2021-10-26 | — | — | US | disclosed |
| WO-1997022019-A1 | METHODS OF MANUFACTURING CONTACT LENSES | NOVARTIS AG (CH) | 1997-06-19 | — | — | WO | disclosed |
| WO-1997000274-A1 | POLYMERIZABLE SILOXANE MACROMONOMERS | NOVARTIS AG (CH) | 1997-01-03 | — | — | WO | disclosed |
| WO-1996031792-A1 | EXTENDED WEAR OPHTHALMIC LENS | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | disclosed |
| WO-1996031546-A1 | PERFLUOROALKYLETHER MACROMER HAVING TWO POLYMERIZABLE GROUPS | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | disclosed |
| WO-1996031545-A1 | POLYMERIZABLE PERFLUOROALKYLETHER MACROMER | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | disclosed |
| WO-1996031548-A1 | CELL GROWTH SUBSTRATE POLYMER | NOVARTIS AG (CH) | 1996-10-10 | — | — | WO | disclosed |